VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Comerica Bank

Comerica Bank lessened its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 64.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 457 shares of the company’s stock after selling 836 shares during the period. Comerica Bank’s holdings in VanEck Pharmaceutical ETF were worth $39,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. SBI Securities Co. Ltd. purchased a new stake in VanEck Pharmaceutical ETF in the 4th quarter worth approximately $29,000. JPMorgan Chase & Co. boosted its position in shares of VanEck Pharmaceutical ETF by 18.6% during the 4th quarter. JPMorgan Chase & Co. now owns 11,316 shares of the company’s stock valued at $976,000 after acquiring an additional 1,774 shares in the last quarter. Raymond James Financial Inc. bought a new position in VanEck Pharmaceutical ETF during the 4th quarter valued at about $1,323,000. Jones Financial Companies Lllp raised its stake in shares of VanEck Pharmaceutical ETF by 1,827.0% in the fourth quarter. Jones Financial Companies Lllp now owns 5,704 shares of the company’s stock worth $492,000 after acquiring an additional 5,408 shares during the last quarter. Finally, Commonwealth Equity Services LLC raised its stake in shares of VanEck Pharmaceutical ETF by 3.6% in the fourth quarter. Commonwealth Equity Services LLC now owns 17,966 shares of the company’s stock worth $1,550,000 after acquiring an additional 631 shares during the last quarter.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $86.83 on Tuesday. The stock has a market cap of $624.31 million, a price-to-earnings ratio of 24.60 and a beta of 0.72. The company has a 50 day moving average of $86.94 and a 200-day moving average of $88.29. VanEck Pharmaceutical ETF has a one year low of $77.67 and a one year high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Tuesday, April 1st were issued a $0.5245 dividend. This represents a $2.10 annualized dividend and a dividend yield of 2.42%. The ex-dividend date was Tuesday, April 1st. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.